Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans
- 15 December 2008
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 76 (12) , 1757-1764
- https://doi.org/10.1016/j.bcp.2008.09.005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitorsBiochemical Pharmacology, 2008
- SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 NonrespondersGastroenterology, 2007
- Effects of Amino Acid Chirality and the Chemical Linker on the Cell Permeation Characteristics of Cyclic Prodrugs of Opioid PeptidesJournal of Medicinal Chemistry, 2006
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003
- Optimizing oral absorption of peptides using prodrug strategiesJournal of Controlled Release, 1999
- Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and RatsPharmaceutical Research, 1998
- The Effect of β-Turn Structure on the Passive Diffusion of Peptides Across Caco-2 Cell MonolayersPharmaceutical Research, 1997
- Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular PathwayPharmaceutical Research, 1997
- How Structural Features Influence the Biomembrane Permeability of PeptidesJournal of Pharmaceutical Sciences, 1996
- The Effect of Conformation on Membrane Permeability of an Acyloxyalkoxy-linked Cyclic Prodrug of a Model HexapeptidePharmaceutical Research, 1996